13G Filing: Biotechnology Value Fund LP and Regulus Therapeutics Inc. (RGLS)
You can access the original SEC filing by clicking here.
Regulus Therapeutics Inc. (RGLS)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Insider Buying at Regulus Therapeutics Inc (RGLS) Sends Stock Soaring
Regulus Therapeutics Inc (NASDAQ:RGLS) shares have jumped $0.30 per share, or 24%, to $1.55 in after hours on Thursday. Traders have bid up shares due to the company disclosing in a regulatory filing...
How Regulus Therapeutics Inc (RGLS) Stacks Up Against Its Peers
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...
Why Are These Stocks Deep in Red Today?
Among the losers today are Regulus Therapeutics Inc (NASDAQ:RGLS), Vista Gold Corp.
What’s Going On With These 5 Trending Stocks?
U.S stocks are trading down ever so slightly on this fine Friday afternoon.
Is Regulus Therapeutics Inc (RGLS) Going to Burn These Hedge Funds?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers and analyze their quarterly...
Trellus Management's Top Biotech Stock Picks For Q4
Trellus Management is a New York-based long/short equity hedge fund founded by Adam Usdan in 1994.
RA Capital Is Expecting A Breakthrough Cardiovascular Drug From This Biotech
The biotechnology industry is up by more than 50% over the last year, but these towering returns don't come without great risk and volatility.
Regulus Therapeutics Inc (RGLS), Trevena Inc (TRVN), Juno Therapeutics Inc (JUNO): RA Capital's Top New Biotech Picks
Peter Kolchinsky’s RA Capital Management filed its latest 13F with the Securities and Exchange Commission in February, and we’ve gone through the data to highlight three of its top new picks in the...
Alkermes Plc (ALKS), Quest Diagnostics Inc (DGX): This Week in Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
